Stavudine 30 MG Oral Capsule

INDICATIONS AND USAGE Stavudine capsules , in combination with other antiretroviral agents, is indicated for the treatment of HIV-1 infection (see Clinical Studies ).

camber pharmaceuticals, inc.

FDA Reported Adverse Reactions
`[1] diarrhoea` `[2] toxicity to various agents` `[3] nausea` `[4] off label use` `[5] vomiting` `[6] neutropenia` `[7] completed suicide` `[8] drug abuse` `[9] drug ineffective` `[10] pyrexia`

4 years ago

CAPSULE ORANGE H 62

HOW SUPPLIED Stavudine capsules are available in the following strengths and configurations Table 13: capsule Strength/Configuration Product Strength capsule Shell Color Markings on capsule (in black Ink) capsules per Bottle NDC No. 15 mg Dark orange and Light orange H 63 60 31722-515-60 100 31722-515-01 1000 31722-515-10 20 mg Dark orange and Dark orange H 64 60 31722-516-60 100 31722-516-01 1000 31722-516-10 30 mg Light orange and Light orange H 62 60 31722-517-60 100 31722-517-01 500 31722-517-05 40 mg Dark orange and Dark orange H 61 60 31722-518-60 100 31722-518-01 500 31722-518-05

More pills like CAPSULE H 62

Related Pills

Stavudine 40 MG Oral Capsule

camber pharmaceuticals, inc.

Stavudine 20 MG Oral Capsule

camber pharmaceuticals, inc.

Stavudine 15 MG Oral Capsule

camber pharmaceuticals, inc.

aripiprazole 5 mg

aurobindo pharma limited

aripiprazole 5 mg

aurobindo pharma limited

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site